Apidra SoloStar
insulin glulisine
- Strength
- 100 [iU]/mL
- Form
- Injection, Solution
- Class
- Insulin Analog
sanofi-aventis U.S. LLC
Not stocked by us — reference only
insulin glulisine
Listed by sanofi-aventis U.S. LLC
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous, Subcutaneous |
| Drug class | Insulin Analog |
| Approval route | BLA — biologic licence |
| NDC code | 0088-2500 |
| FDA application | BLA021629 |
| RxNorm concept | 485210 |
| Package sizes listed | 2 |
| Marketed since | February 2009 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
insulin glulisine
sanofi-aventis U.S. LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.